The efficacy of a single metered dose inhaler containing a combination of fenoterol (100 ,ug/puff) and ipratropium bromide (40 ,ig/puff) has been assessed in 12 asthmatics. We conclude that the bronchodilator effect of 2 puffs of the combination inhaler was significantly greater than that achieved by 2 puffs of salbutamol (100,ug/puff).
Introduction
Both salbutamol and fenoterol are selective 2 adrenergic agonists which produce effective bronchodilatation in asthma. Ipratropium bromide is a synthetic anti-cholinergic bronchodilator which has been assessed in both asthma and bronchitis (Poppius and Salorinne, 1973; Petrie and Palmer, 1975) . In severe chronic bronchitis and emphysema, it has been shown to be at least as effective as salbutamol, the most commonly used /82 adrenergic agonist with bronchodilator properties (Douglas et al., 1979) .
The combination of fenoterol and ipratropium bromide has been shown to produce a greater bronchodilator response than that achieved by either agent alone both in asthma (Martin, Berend and Harrison, 1979) and chronic bronchitis (Addis, Barclay and Chang, 1979; Anderson, Jariwalla and Turnbull, 1980) . This combination has recently become available in a single metered dose inhaler.
In a double-blind, crossover study we have compared the onset of action, peak effect and side effects of this combination with salbutamol similarly administered.
Methods
Twelve chronic stable asthmatics (5 male, mean age 52 years, range 24-75 years, mean duration of disease 15-5 years) were assessed at the same time on 2 consecutive days having taken no bronchodilator for at least 12 hr. Five patients were on inhaled 2 adrenergic agonists only, 5 were on inhaled and 2 were on oral corticosteroids. All were non-smokers. min inclusive (P<0 05 for 105 min, and P<0-01 at 75, 90 and 120 min). However, there were no significant differences observed between the treatments for percentage increase in FVC. There was no significant difference between salbutamol and the combination with respect to pulse rate and blood pressure before and after treatment and no difference related to the order of treatments.
Tremor was a common side effect (5 out of 12) but was equally common with salbutamol and the combination. Two patients complained of the taste of the combination. One patient felt nauseated with the combination.
DIwssion
The different sites of action of 2 adrenergic agonists and anti-cholinergic agents has led to their use in combination in patients with chronic airways obstruction. The combination of fenoterol with ipratropium bromide has been shown to produce 4dditional bronchodilatation (Martin, Berend and Harrison, 1979) and in a single metered dose inhaler, to provide optimal bronchodilatation with few side effects (Ulmer, 1979) . This combination inhaler is now widely available in the U.K. and may increase compliance in those patients shown to respond to both agents. There is, as yet however, no published information on the efficacy of this combination in asthma.
We conclude that, at conventional doses (2 puffs of the metered dose inhaler, Duovent [the combination of fenoterol (100 iLg/puff) and ipratropium bromide (40 ,tg/pufl)] produced significantly greater bronchodilator effect than salbutamol (100 ,ug/puff 
